Sana raised about $165 million, before underwriting discounts, commissions and other expenses, through an underwritten public ...
Previous stops include Biogen, Seagen and Amgen. Sana, which launched in 2019 ... In the fourth quarter of last year, Sana laid off about 29% of its workforce, or almost 130 workers.
Horizon had approximately 2,100 employees in 2022. Earlier this year, Amgen announced plans to cut 450 jobs, citing drug ...
April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce ... with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
April 4 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due ... with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales ... its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita ...
Thompson joins from Amgen, where she was EVP of rare disease ... but Fierce Biotech calculated at least 2,398 people laid off from the 25 companies reporting numbers of employees affected for ...
London: Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce ... Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira biosimilar ...
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales ... its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita ...
Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor US sales ... Swiss drugmaker Sandoz launched its biosimilar Hyrimoz with the same prices as Boehringer and ...
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce ... Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
The negotiation process officially kicked off Feb. 1 with the government’s ... Novo Nordisk and Amgen each have products subject to the negotiations. Elsewhere in the drug pricing realm ...